Cargando…
Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma
Malignant pleural mesothelioma (MPM) is an aggressive malignancy of the pleura that is currently incurable due to the lack of an effective early diagnostic method and specific medication. The CDKN2A (p16) and NF2 genes are both frequently mutated in MPM. To understand how these mutations contribute...
Autores principales: | Karnan, Sivasundaram, Ota, Akinobu, Murakami, Hideki, Rahman, Md Lutfur, Hasan, Muhammad Nazmul, Wahiduzzaman, Md, Hanamura, Ichiro, Quang Vu, Lam, Inoko, Akihito, Hyodo, Toshinori, Konishi, Hiroyuki, Tsuzuki, Shinobu, Hosokawa, Yoshitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674463/ https://www.ncbi.nlm.nih.gov/pubmed/33298865 http://dx.doi.org/10.1038/s41420-020-00364-1 |
Ejemplares similares
-
Establishment and characterization of CRISPR/Cas9‐mediated NF2
(−/−) human mesothelial cell line: Molecular insight into fibroblast growth factor receptor 2 in malignant pleural mesothelioma
por: Wahiduzzaman, Md, et al.
Publicado: (2018) -
CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma
por: Karnan, Sivasundaram, et al.
Publicado: (2023) -
Novel ATP‐competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells
por: Yamaji, Masayuki, et al.
Publicado: (2017) -
Experimental strategies to achieve efficient targeted knock-in via tandem paired nicking
por: Rahman, Md. Lutfur, et al.
Publicado: (2021) -
Biallelic loss of FAM46C triggers tumor growth with concomitant activation of Akt signaling in multiple myeloma cells
por: Kanasugi, Jo, et al.
Publicado: (2020)